Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanjeevini
- Development stage
- Unknown
- Lead developer
- Ankh Pharmaceuticals
- Administration
- Oral
01
Overview
Sanjeevini is a branded herbal and Ayurvedic supplement developed and marketed by Ankh Pharmaceuticals. It is positioned as a consumer health product for general wellness, specifically indicated for the treatment of anemia and general debility. As a polyherbal formulation, it does not possess a single defined molecular target or mechanism of action, nor is it undergoing conventional clinical trial phases (Phase 1-3) typical of pharmaceutical drug candidates. It is part of a broader portfolio of 13 herbal products offered by the company for various indications including diabetes support, digestion, and immunity.
- Brand names
- Sanjeevini
- Other names
- Sanjeevini
Beyond the preview
Go deeper on Sanjeevini.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanjeevini.